Butterfly Network Provides Commentary on Midjourney Medical’s Full Body Ultrasound Scanner Announcement
Midjourney reveals the technology behind its previously disclosed agreement with Butterfly, reimagining wide-scale access to whole body imaging and personalized health insights.
Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today provided commentary following Midjourney's public announcement of Midjourney Medical and The Midjourney Scanner: a full-body tomographic imaging machine.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618923795/en/
The current scanner prototype incorporates 40 Butterfly Ultrasound-on-Chip™ imaging modules per system, licensed under a co-development agreement between the two companies. Future generations are expected to utilize substantially more imaging modules, reflecting the platform’s planned evolution and scalability. Additional details regarding the platform and Midjourney’s long-term objectives are available in their announcement: https://www.midjourney.com/medical/blogpost
